INC Research/inVentiv now Syneos Health

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/manaemedia)
(Image: iStock/manaemedia)

Related tags: Management occupations

INC Research/inVentiv Health is starting the new year with a rebrand after merging to create one of the largest biopharmaceutical outsourcing providers in 2017.

The company​, with a combined staff of more than 21,000 employees across more than 60 counties, will now be known as Syneos Health, Inc., effective January 4, 2018.

Syneos Health common shares will trade on the Nasdaq Global Select Market under the new ticker symbol “SYNH” by January 9, 2018.

"Since close, we’ve quickly assembled an Integrated Solutions Group, bringing together seasoned industry product strategists with regulatory, clinical, commercial and real world expertise​," Alistair Macdonald, CEO of Syneos Health told

"This group is working with customers across the small to mid to large continuum to determine the right mix of clinical and commercial capabilities to produce a higher likelihood of launch success,​” he added. 

Also this week, the company announced that Greg Rush is stepping down as chief financial officer (CFO) to pursue a different opportunity. The company has initiated the search for a replacement.

The current executive vice president and CFO of the company’s commercial solutions business will be appointed as interim CFO at the end of April if a replacement has not been found, according to the company.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more